In the August 1 issue of G&D, Dr. Ronald Evans (Salk Institute) and colleagues report on their discovery that mutations in the mouse gene encoding PPAR adversely affect lactation milk quality, and have serious health consequences for nursing pups.
By examining PPAR functions in vivo, our work reveals an unexpected link between diet, inflammation and the quality of mothers milk, explained Dr. Evans.
PPAR (peroxisome proliferator-activator receptor gamma) is a nuclear receptor that is known to regulate metabolism and inflammation in various organisms. In fact, human PPAR is the main target of the drug class of thiazolidinediones (TZDs), which is used to manage diabetes.
Dr. Evans and colleagues sought to determine the role of PPAR in the lactating mammary gland. They generated a strain of mice that, as adults, lacked PPAR only in hematopoietic and endothelial cells. When these PPAR-deficient animals became mothers, they appeared normal, but the milk they produced most certainly was not.
"We were delighted and surprised by the discovery because it directly explores one of life's most common events - breast feeding. These findings will enhance the understanding of why milk is healthful and the molecular pathways that create the bodies own quality control pipe line," says Dr. Evans.
The researchers noticed that pups of the PPAR-deficient females who were, themselves, genetically normal - were displaying a number of abnormalities, most noticeably marked hair loss across their trunks and growth retardation. The scientists determined that these abnormalities were due to their ingestion of toxic milk from their PPAR-deficient mothers: Either fostering by PPAR-normal mothers or weaning to solid food effectively cured these small and balding pups.
Through a variety of experimental approaches, Dr. Evans and colleagues determined that PPAR loss results in increased levels of pro-inflammatory lipids being release
Contact: Heather Cosel
Cold Spring Harbor Laboratory